Health

SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine

BOSTON and SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and accessibility of scientific discovery, today announced at theAssociation for Molecular Pa...

2025-11-11 21:01 821

Waters Boosts Lab Productivity and Sample Throughput with Launch of its Charged Aerosol Detector Designed for Empower Software

* Drives efficiency and reliability in Quality Control and Development environments, integrating seamlessly with world-class Empower™ Chromatography Data System (CDS). * Mitigates CDS communication errors encountered in up to 70% of multi-vendor LC-CAD configurations.1 * Delivers near-unive...

2025-11-11 21:00 901

The Frequency School Launches First 'World Frequency Day' on 11/11 to spread global unity through music and wellness

* New international day aims to raise awareness about positive impacts of sound frequencies on mental and physical health * Declared by the Frequency School, a global initiative by U.S. Grammy-nominated producerMaejor to promote music therapy and wellness around the globe * World Frequency ...

2025-11-11 18:11 1289

Apollo Cancer Centres Turns Chocolates into Health Reminders with 'Check-Olate'

NEW DELHI, Nov. 11, 2025 /PRNewswire/ -- To observe this year's Breast Cancer Awareness Month, Apollo Cancer Centres (ACCs) recently launched acrossIndia a unique initiative that blended indulgence with awareness through'Check-Olate', a sweet treat that carries an even sweeter reminder: take a mo...

2025-11-11 17:15 932

Guo Guangchang: Fosun Strengthens Globalization Capabilities, Accelerates Innovation through Open Cooperation

HONG KONG, Nov. 11, 2025 /PRNewswire/ -- On 8 November, Guo Guangchang, Chairman of Fosun International, attended the 3rd Pujiang Biopharmaceutical Original Innovation Conference 2025. During the conference, Guo Guangchang stated, "At this crucial juncture today,China's pharmaceutical innovation ...

2025-11-11 15:41 1946

OMNIBOT Showcases How Connectivity Expands Possibilities in Live Telesurgery at Chilean Urology Congress

-The live telesurgery took place during the XLVI Annual Congress of the Chilean Society of Urology, which also marked the Society's 100th anniversary. This procedure highlights how network connectivity is enabling new forms of surgical collaboration. SINGAPORE, Nov. 11, 2025 /PRNewswire/ -- Duri...

2025-11-11 13:00 1147

NOVI Health Launches "It Starts with One: Taking Charge This World Diabetes Month" Campaign to Support Awareness and Wellness in Singapore

SINGAPORE, Nov. 11, 2025 /PRNewswire/ -- In recognition of Diabetes Awareness Month, NOVI Health is honoured to launch"It Starts with One: Taking Charge This World Diabetes Month", a campaign dedicated to raising awareness, promoting healthy living, and supporting the diabetes community inSingapo...

2025-11-11 11:00 1280

Molly Ally - a Plant-Based Ice Cream Success from Passion and Pain Points

BANGKOK, Nov. 11, 2025 /PRNewswire/ -- Molly Ally , a plant-based ice cream brand founded by threeChulalongkorn University alumni — Rati Bowornmongkolsak, Chotima Meemungtham, and Kanchanit Bupphachuen — began as a maste...

2025-11-11 10:41 1121

Shilpa Pharma Lifesciences Awarded EcoVadis Gold Medal for Outstanding Sustainability Practices

RAICHUR, India, Nov. 11, 2025 /PRNewswire/ -- Shilpa Pharma Lifesciences Limited, a material subsidiary of Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), has been awarded the prestigiousGold Medal by EcoVadis, the world's most trusted provider of business sustainability ratings. The com...

2025-11-11 09:15 870

GLAC Biotech Wins Double Honors at the iSEE Global Innovation Awards Lactobacillus plantarum PL-02 Sets a New Benchmark for Functional Probiotics

TAIPEI, Nov. 11, 2025 /PRNewswire/ -- GLAC Biotech, a leading innovator in probiotics and postbiotics research, proudly announces another milestone on the global stage. Its flagship strain,Lactobacillus plantarum PL-02, has been honored withtwo major awards at the 7th iSEE Global Innovation Award...

2025-11-11 09:00 923

Shilpa Medicare Announces Positive Phase 3 Results for OERIS™ -- A Novel Once-Weekly Ondansetron Extended-Release Injection for Chemotherapy-Induced Nausea and Vomiting (CINV)

Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondansetron injections RAICHUR, India, Nov. 11, 2025 /PRNewswire/ -- Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED) announced the successfu...

2025-11-11 09:00 900

Vexev's VxWave System Successfully Meets Clinical Endpoints in Landmark Study Evaluating Robotic Ultrasound Scanning for Mapping Vascular Access at U.S. Renal Care Dialysis Clinics

* VxWave Ultrasound Imaging System demonstrated 94% scanning success rate and 100% data adequacy rate for vascular access creation strategies in CANSCAN trial * New insights into vascular anatomy made possible by standardized image acquisition and reporting * VxWave System has the potential t...

2025-11-11 05:32 1164

TraceLink Customers Demonstrate Readiness as DSCSA Dispenser Deadline Arrives

TraceLink Continues to Set the Standard for United States Drug Supply Chain Security (DSCSA) Leadership, Proven by Real-World Success, Industry Adoption, and Superior Service BOSTON, Nov. 10, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestr...

2025-11-10 23:00 1058

Brii Biosciences Presents Late-Breaking Data from Ongoing Phase 2 ENSURE Study at AASLD 2025, Reinforcing BRII-179's Potential as a Curative Treatment for Chronic Hepatitis B

* Cohort 4 follow-up confirms durable hepatitis B surface antigen (HBsAg) loss at 24 weeks post end of treatment (EOT) in BRII-179 anti-HBs responders treated with elebsiran plus pegylated interferon alfa (PEG-IFNα) * Data suggest the potential to shorten PEG-IFNα treatment duration for BRII-...

2025-11-10 21:30 2004

Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting

- Data demonstrates ofirnoflast's efficacy in myelodysplastic syndrome (MDS) with robust and sustained hematologic responses – - A novel mechanism targeting NEK7 and NLRP3 inflammasomes shows promise across multiple myeloid neoplasms – - Preclinical data reveal potential applications in hemolyti...

2025-11-10 21:15 1037

MediTrust Health and Sino Biopharm Sign Strategic Cooperation Agreement at CIIE 2025 to Advance Drug-Insurance Integration New Model

HONG KONG, Nov. 10, 2025 /PRNewswire/ -- Shanghai, November 10, 2025 – During the 8th China International Import Expo (CIIE), Sino Biopharmaceutical Limited ("Sino Biopharm") and Shanghai MediTrust Health Technology Group Co., Ltd. ("M ediTrustHealth") signed a strategic cooperation agreement. The...

2025-11-10 14:18 1128

Rona Therapeutics Presents Phase 1 Data for RN0361, a Long-Acting APOC3-Targeting siRNA, at the American Heart Association 2025 Scientific Sessions

NEW ORLEANS, Nov. 10, 2025 /PRNewswire/ -- Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, presented highlights of Phase 1 clinical data for RN0361, a long-acting Apolipoprotein C3 (ApoC3) siRNA. RN0361 achieved potent, durable reductions in ApoC3 and triglycer...

2025-11-10 12:00 1293

Kelun-Biotech Presented TROP2 ADC Sacituzumab Tirumotecan Results From Multiple Clinical Studies at the 2025 CCHIO Congress

CHENGDU, China, Nov. 10, 2025 /PRNewswire/ -- From November 6 to 9, the 2025 Chinese Congress on Holistic Integrative Oncology (CCHIO) was held in Kunming, Yunnan. This conference was jointly organized by the Chinese Anti-Cancer Association (CACA), the Tengchong Science Forum Organizing Committee ...

2025-11-10 10:01 1286

ICP DAS-BMP Attends MOU Signing Ceremony to Mark a New Milestone in Medical-Grade TPU Materials

HSINCHU, Nov. 10, 2025 /PRNewswire/ -- ICP DAS-BMP participated in the Strategic Memorandum of Understanding (MOU) signing ceremony organized by Towards Buddha Co., Ltd. onOctober 28, where it showcased its R&D achievements and diverse applications in medical-grade TPU materials. Moving forward, ...

2025-11-10 08:45 1066

Xinhua Silk Road: E. China's Weihai City establishes 18 TCM health tourism demonstration bases

BEIJING, Nov. 8, 2025 /PRNewswire/ -- Weihai, a prefecture-level city in east China's Shandong Province, has seen the establishment of 18 traditional Chinese medicine (TCM) health tourism demonstration bases, including the Weihai Tianmu Hot Spring Resort, as the city has emphasized the deep integ...

2025-11-08 20:48 1753
1 ... 567891011 ... 563